Placental glutathione S-transferase correlates with cellular proliferation during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

https://doi.org/10.1016/j.etp.2007.02.010Get rights and content

Abstract

Taking into consideration that glutatione S-transferase (GST) and cellular proliferation play a crucial role during carcinogenesis, the goal of this study was to investigate the expression of placental GST, called GST-P, and proliferating cellular nuclear antigen (PCNA) by means of immunohistochemistry during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide (4NQO). This is a useful model for studying oral squamous cell carcinoma phase by phase. Male Wistar rats were distributed into three groups of 10 animals each and treated with 50 ppm 4NQO solution by drinking water for 4, 12 or 20 weeks. Ten animals were used as negative control. GST-P positive foci were detected in non-neoplastic oral cells at 4 weeks of 4NQO administration. In the same way, GST-P positive cells were detected in pre-neoplastic lesions and squamous cell carcinomas induced after 12 and 20 weeks-treatment, respectively. None of the control animals expressed GST-P positive cells. Regarding cellular proliferation, PCNA positive nuclei were higher at 12 and 20 weeks following 4NQO exposure (p<0.05) when compared to negative control. These results suggest that the expression of GST-P is correlated with cellular proliferation, in which GST-P is associated with risk and progression of oral cancer, whereas PCNA is closely involved during neoplastic conversion.

Introduction

Squamous cell carcinoma is the most common malignancy that affects the human oral cavity (Sakai and Tsuchida, 1992). Despite recent advances in therapeutic modalities, the prognosis of patients with oral squamous cell carcinoma has not been improved significantly in the last decades (Ribeiro et al., 2004). Herein, it is desirable to examine the precise pathobiological mechanisms involved in oral tumorigenesis in order to introduce reliable biomarkers to prevent oral squamous cell carcinomas. The most used animal models in oral cancer research are the hamster buccal pouch by fat-soluble 7,12 dimethylbenzanthracene (DMBA), and the rat tongue by water-soluble 4-nitroquinoline 1-oxide (4NQO). Considering that one of the most important routes of oral carcinogens is through liquid containing water-soluble carcinogens, 4NQO is well suited in examining the role of xenobiotics in experimental oral carcinogenesis (Tanaka et al., 2002). Based on the multi-step process of carcinogenesis characterized by initiation, promotion and tumor progression, chronic administration of 4NQO in drinking water simulates rat tongue carcinogenesis like human counterpart (Ohne et al., 1985; Nishimura, 1999; Niwa et al., 2001; Okazaki et al., 2002; Vered et al., 2003; Ribeiro et al., 2005).

Glutatione S-transferases (GSTs) are a family of enzymes involved in detoxification of xenobiotics. GSTs exist as homo- or heterodimers and have been grouped into at least seven distinct classes (Hayes and Pulford, 1995; Strange et al., 2000). The main function of GSTs is to catalyze the conjugation of glutathione to an electrophilic site of a broad range of potentially toxic and carcinogenic compounds, thereby making such compounds less biologically active and enabling their excretion (Hayes and Pulford, 1995). Placental GST, called GST-P, is the main isoform in normal placental tissue and comprises 67% of the total GST concentration in this phase (Zusterzeel et al., 1999). During development, GST-P decreases in concentration and is absent in adult tissues (Fatemi et al., 2006). Interestingly, GST-P-positive foci have been detected in adult tissues during medium-term hepatocarcinogenesis assay being regarded a suitable biomaker for early detection of liver neoplasms (Fonseca et al., 2005; Kitano et al., 2006; Uda et al., 2006). However, the real significance of GST-P positive cells during rat tongue carcinogenesis induced by 4NQO is fairly limited in literature (Li, 1999).

It has been well established that tumor cell proliferation activity plays an important role in tumorigenesis (Tumuluri et al., 2004). Among proliferating cellular markers, PCNA is a DNA polymerase delta auxiliary protein of 36 kDa, which is closely related to the replication of DNA and is indispensable to cell proliferation. Since the PCNA level increases rapidly in mid-G1, remains elevated throughout the S phase, and begins to decrease from G2/M to G1 (Linden et al., 1992), a decrease in the number of PCNA-positive cells reflects a decrease in S phase cells and thus a reduced proliferative activity. To our knowledge, there are no studies that addressed concomitant expression of GST-P and PCNA during experimental oral carcinogenesis so far. As a result and because of inapropriate evidence, the present study was undertaken to investigate the expression of GST-P positive foci and PCNA-positive cells on 4NQO-induced rat tongue carcinogenesis.

Section snippets

Animals and experimental design

All experimental protocols involving animals were conformed to procedures described in the Guiding Principles for the Use of Laboratory Animals.

Forty male Wistar rats (8 weeks old) weighting approximately 250 g, were obtained from Centro de Bioterismo (CEMIB), Universidade Estadual de Campinas, SP, Brazil. They were maintained under controlled conditions of temperature (24±2 °C), light-dark periods of 12 h, and with free access to water and commercial diet (Nuvital PR, Brazil). The animals were

Histopathological evaluation following 4NQO treatment

No histopathological changes in tongue epithelia were observed in the control group (Fig. 1a) nor after 4-week treatment with 4NQO. Nevertheless, a primary histopathological change, i.e., hyperplasia and hyperkeratosis with the spinous cell layer gradually thickened was evidenced after 12-week treatment (Fig. 1b). In this period, mild epithelial dysplasia was diagnosed in three animals as well. At 20 weeks, moderate/severe oral dysplasia (Fig. 1c) and squamous cell carcinoma in the tongue (Fig.

Discussion

Carcinogenesis is a multi-step process, which is characterized by genetic, epigenetic, and phenotypic changes (Sugimura et al., 1992). Such changes involve genetic damage, mutation in critical genes related to the control of cell division, cell death and metastatic potential, and activation of signalizing or metabolic pathways that give the cells favorable growth and survival characteristics (Sarasin, 2003). In patients, the molecular analysis of these multiple steps is hampered, due to the

Acknowledgments

The authors are grateful to Paulo Roberto Cardoso and Maria Luiza Falaguera Ardanaz for their technical assistance. This work was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant numbers: 02/09454-0 and 03/10030-2).

References (42)

  • M. Tubiana et al.

    Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival

    Radiother Oncol

    (1989)
  • N. Uda et al.

    Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis

    J Nutr

    (2006)
  • M. Vered et al.

    Histomorphologic and morphometric changes in minor salivary glands of the rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis

    Oral Oncol

    (2003)
  • L. Zhang et al.

    Development of glutathione S-transferase placental form (GST-P) stained foci during hamster buccal pouch mucosa carcinogenesis

    Cancer Lett

    (1992)
  • P.L. Zusterzeel et al.

    Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies

    Obstet Gynecol

    (1999)
  • L.F. Barbisan et al.

    Agaricus blazei (Himematsutake) does not alter the development of rat diethylnitrosamine-initiated hepatic preneoplastic foci

    Cancer Sci

    (2003)
  • L.I. Esteves et al.

    DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?

    Mol Carcinog

    (2005)
  • Fatemi F, Allameh A, Dadkhah A, Forouzandeh M, Kazemnejad S, Sharifi R. Changes in hepatic cytosolic glutathione...
  • P.M. Fonseca et al.

    Targeting to C-terminal myosin heavy chain may explain mechanotransduction involving focal adhesion kinase in cardiac myocytes

    Circ Res

    (2005)
  • J.D. Hayes et al.

    The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

    Crit Rev Biochem Mol Biol

    (1995)
  • W.B. Jakoby

    The glutathione S-transferases: a group of multifunctional detoxification proteins

    Adv Enzymol Relat Areas Mol Biol

    (1978)
  • Cited by (27)

    • Development of a 4-nitroquinoline-1-oxide model of lymph node metastasis in oral squamous cell carcinoma

      2013, Oral Oncology
      Citation Excerpt :

      In the present study, the 4NQO concentration was 200 μg/ml, and the duration of 4NQO treatment was 20 weeks. In most previous studies,10,14–17 the 4NQO concentrations in drinking water ranged from 10 μg/ml to 200 μg/ml, and the duration of 4NQO treatment ranged from 8 to 16 weeks. Thus, the 4NQO concentration and the duration of 4NQO treatment in the present study were higher and longer, respectively, than those of most previous studies, and we successfully developed a lymph node metastasis model.

    • The role of the TP53 gene during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

      2011, Experimental and Toxicologic Pathology
      Citation Excerpt :

      Since one of the most important routes of oral carcinogenesis is through liquid containing water-soluble carcinogens, 4NQO is suitable for examining the role of xenobiotics in experimental oral carcinogenesis (Tanaka et al., 2002). Based on the multi-step process of carcinogenesis, which is characterized by initiation, promotion, and tumor progression, chronic administration of 4NQO in drinking water stimulates rat tongue carcinogenesis in a manner similar to its human counterpart (Nishimura, 1999; Ribeiro et al., 2005; 2007; Kitakawa et al., 2006; Silva et al., 2007). The human Tp53 gene has been reported to be a tumor suppressor gene.

    View all citing articles on Scopus
    View full text